Analyst Coverage Initiated: VERV rating Outperform by BMO Capital Markets
Price Target: $48
Report Date: 06-17-2022
Symbol: VERV - Verve Therapeutics
Sector:
Industry:
Analyst Coverage Initiated: VERV rating Outperform by BMO Capital Markets
Price Target: $48
,